OBJECTIVE: To investigate and compare the antileishmanial effects of CAPE and (CAPE)PLGA NPs on Leishmania infantum (L. infantum) promastigotes and amastigotes in vitro. METHODS: Efficacies of CAPE, (CAPE)PLGA NPs and free PLGA nanoparticles (NPs) on promastigotes were evaluated using MTT and promastigote count assays, and their anti-amastigote effects were determined via infection index analysis. Griess reaction was also performed to calculate nitric oxide production of macrophages exposed to investigated molecules. RESULTS: It was determined that CAPE and (CAPE)PLGA NPs demonstrated significant inhibitory effects on L. infantum promastigotes and amastigotes, while free NPs did not exhibit any meaningful antileishmanial effectiveness. The IC50 values of CAPE for L. infantum promastigotes and amastigotes were assessed as (51.0 ± 0.8) and (19.0 ± 1.4) μg/mL, respectively (P < 0.05). On the other side, it was revealed that (CAPE)PLGA NPs had superior antileishmanial activity on both forms of parasites since its IC50 values for L. infantum promastigotes and amastigotes were (32.0 ± 1.3) and (8.0 ± 0.9) μg/mL, respectively (P < 0.05). It was also determined that both agents strongly stimulated nitric oxide production of macrophages. CONCLUSIONS: The obtained results show that (CAPE)PLGA NPs have a great potential to be especially used in treatment of visceral leishmaniasis; however, in vivo antileishmanial screening of these molecules should be performed in the near future.
OBJECTIVE: To investigate and compare the antileishmanial effects of CAPE and (CAPE)PLGA NPs on Leishmania infantum (L. infantum) promastigotes and amastigotes in vitro. METHODS: Efficacies of CAPE, (CAPE)PLGA NPs and free PLGA nanoparticles (NPs) on promastigotes were evaluated using MTT and promastigote count assays, and their anti-amastigote effects were determined via infection index analysis. Griess reaction was also performed to calculate nitric oxide production of macrophages exposed to investigated molecules. RESULTS: It was determined that CAPE and (CAPE)PLGA NPs demonstrated significant inhibitory effects on L. infantum promastigotes and amastigotes, while free NPs did not exhibit any meaningful antileishmanial effectiveness. The IC50 values of CAPE for L. infantum promastigotes and amastigotes were assessed as (51.0 ± 0.8) and (19.0 ± 1.4) μg/mL, respectively (P < 0.05). On the other side, it was revealed that (CAPE)PLGA NPs had superior antileishmanial activity on both forms of parasites since its IC50 values for L. infantum promastigotes and amastigotes were (32.0 ± 1.3) and (8.0 ± 0.9) μg/mL, respectively (P < 0.05). It was also determined that both agents strongly stimulated nitric oxide production of macrophages. CONCLUSIONS: The obtained results show that (CAPE)PLGA NPs have a great potential to be especially used in treatment of visceral leishmaniasis; however, in vivo antileishmanial screening of these molecules should be performed in the near future.
Authors: Nazeh M Al-Abd; Zurainee Mohamed Nor; Quazim O Junaid; Marzida Mansor; M S Hasan; Mustafa Kassim Journal: Pathog Glob Health Date: 2017-10-25 Impact factor: 2.894
Authors: Aiman Abu Ammar; Abed Nasereddin; Suheir Ereqat; Mary Dan-Goor; Charles L Jaffe; Eyal Zussman; Ziad Abdeen Journal: Drug Deliv Transl Res Date: 2019-02 Impact factor: 4.617
Authors: Abdul Waris; Misbahud Din; Asmat Ali; Shakeeb Afridi; Abdul Baset; Atta Ullah Khan; Muhammad Ali Journal: Open Life Sci Date: 2021-01-20 Impact factor: 0.938
Authors: Ali Khamesipour; Amitis Ramezani; Tahereh Zadeh Mehrizi; Mehdi Shafiee Ardestani; Hasan Ebrahimi Shahmabadi; Mostafa Haji Molla Hoseini; Nariman Mosaffa Journal: Int J Nanomedicine Date: 2019-09-24
Authors: Mayara Cristina Pinto da Silva; Jefferson Mesquita Brito; Amalia Dos Santos Ferreira; Andre Alvares Marques Vale; Ana Paula Azevedo Dos Santos; Lucilene Amorim Silva; Paulo Vitor Soeiro Pereira; Flavia Raquel Fernandes Nascimento; Roberto Nicolete; Rosane Nassar Meireles Guerra Journal: Evid Based Complement Alternat Med Date: 2018-06-25 Impact factor: 2.629